Filter Results:
(26)
Show Results For
- All HBS Web
(118,338)
- Faculty Publications (26)
Show Results For
- All HBS Web
(118,338)
- Faculty Publications (26)
←
Page 2 of 26
Results
- 2020
- Working Paper
Scientific Production: An Exploration into Organization, Resource Allocation, and Funding
By: Jerry Thursby, Marie Thursby, Karim R. Lakhani, Kyle R. Myers, Nina Cohodes, Sarah Bratt, Dennis Byrski, Hannah Cohoon and Maria Roche
Production of scientific knowledge is core to civilizational advancement in economic and material wellbeing of societies. Despite its fundamental importance, however, a systematic effort to quantitatively study the factors underlying scientific production, particularly... View Details
- Fall 2019
- Article
Endogenous Productivity of Demand-Induced R&D: Evidence from Pharmaceuticals
By: Kyle Myers and Mark Pauly
We examine trends in the productivity of the pharmaceutical sector over the past three decades. Motivated by Ricardo’s insight that productivity and rents are endogenous to demand when inputs are scarce, we examine the industry’s aggregate R&D production function.... View Details
Keywords: Innovation; Productivity; Pharmaceuticals; Innovation and Invention; Performance Productivity; Pharmaceutical Industry
Myers, Kyle, and Mark Pauly. "Endogenous Productivity of Demand-Induced R&D: Evidence from Pharmaceuticals." RAND Journal of Economics 50, no. 3 (Fall 2019): 591–614.
- 2018
- Chapter
Pharmaceutical Trends, Not What They Seem
By: Kyle Myers and Mark Pauly
Myers, Kyle, and Mark Pauly. "Pharmaceutical Trends, Not What They Seem." In Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation, by Philip A. Rea, Mark V. Pauly, and Lawton R. Burns, 18–42. Cambridge: Cambridge University Press, 2018.
- March 2018 (Revised September 2023)
- Case
X: The Foghorn Decision
In February 2016, Kathy Hannun—a project leader at X, Alphabet Inc.'s so-called "moonshot factory"—had to prepare a recommendation for the senior leadership of X regarding the future of Foghorn, a project she was leading to develop a carbon-neutral process for... View Details
Keywords: Innovation; R&D Project Management; Radical Innovation; Clean Technology; Innovation and Management; Technological Innovation; Energy; Research and Development; Projects; Management; Decision Choices and Conditions; Technology Industry; Energy Industry; Green Technology Industry; California
Huckman, Robert S., Karim R. Lakhani, and Kyle R. Myers. "X: The Foghorn Decision." Harvard Business School Case 618-060, March 2018. (Revised September 2023.)
- Forthcoming
- Article
How Important Is Editorial Gatekeeping? Evidence from Top Biomedical Journals
By: Joshua L. Krieger, Kyle R. Myers and Ariel D. Stern
We examine editors' influence on the scientific content of academic journals by unpacking the role of three major forces: journals' missions, aggregate supply of and demand for specific topics, and scientific homophily via editorial gatekeeping. In a sample of top... View Details
Keywords: Editors; Biomedical Research; Editorial Gatekeeping; Scientific Homophily; Intellectual Capital; Mission and Purpose; Journals and Magazines; Intellectual Property; Innovation and Invention; Human Capital; Higher Education; Publishing Industry
Krieger, Joshua L., Kyle R. Myers, and Ariel D. Stern. "How Important Is Editorial Gatekeeping? Evidence from Top Biomedical Journals." Review of Economics and Statistics (forthcoming). (Pre-published online May 29, 2023.)
- Research Summary
Overview
By: Kyle R. Myers
Professor Myers studies the economics of what determines the rate and direction of innovation. He has examined the reallocation of scientists through the use of targeted research grants at the National Institutes of Health, and is working to further understand how... View Details
Keywords: Technology Networks; Commercialization; Science-Based Business; Research and Development; Knowledge Management; Patents; Innovation Strategy; Technological Innovation; Health Care and Treatment; Entrepreneurship; Health; Innovation and Invention; Science; Technology; Knowledge; Intellectual Property; Economics; Microeconomics; Biotechnology Industry; Health Industry; Pharmaceutical Industry; Technology Industry